Formulary for Laboratory Animals

(2)
Formulary for Laboratory Animals image
ISBN-10:

0813810485

ISBN-13:

9780813810485

Edition: 3
Released: Jan 24, 2005
Publisher: Wiley/Blackwell
Format: Paperback, 203 pages

Description:

Formulary for Laboratory Animals is an invaluable reference for treatment of laboratory animals and pocket pets. Drugs are listed alphabetically and categorized in five sections based on pharmacologic activity and animal species.

This at-a-glance pocket reference is valuable for students and practitioners of veterinary medicine, researchers and laboratory technicians who prescribe or administer drugs used on common laboratory animals.

The third edition includes a stronger international component, coverage of several new drugs, hundreds of additional dosages, and a thorough update throughout based on the most current research. The third edition also includes a chapter describing how to estimate drug dosages among species using allometric scaling methodology.

Best prices to buy, sell, or rent ISBN 9780813810485




Related Books

Frequently Asked Questions about Formulary for Laboratory Animals

You can buy the Formulary for Laboratory Animals book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $109.90 on Amazon and is available from 1 sellers at the moment.

If you’re interested in selling back the Formulary for Laboratory Animals book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the Formulary for Laboratory Animals book, the best buyback offer comes from and is $ for the book in good condition.

The Formulary for Laboratory Animals book is in very low demand now as the rank for the book is 7,755,128 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.

Not enough insights yet.